Paeds · fetal-neonatal-and-perinatal
Hearing loss in high-risk neonates
Also known as Neonatal hearing loss · Congenital hearing impairment · Newborn hearing screening · Auditory neuropathy spectrum disorder in the NICU · JCIH risk indicators
Fellowship guide to hearing loss in high-risk neonates — the JCIH 1-3-6 screening pathway, why the NICU infant is screened with AABR rather than OAE, the risk indicators that demand ongoing surveillance, and the early-intervention ladder that protects language development when permanent loss is confirmed.
On this page
Related topics
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Screening a NICU infant with OAE alone misses auditory neuropathy spectrum disorder — use AABR, because the NICU population carries the highest ANSD burden
- A 'pass' on the newborn screen does not exclude hearing loss in a high-risk infant — congenital CMV and genetic causes produce progressive or late-onset loss that emerges months later
- A baby who refers on the first screen and is lost to follow-up is the single most dangerous outcome of universal screening — every refer must be tracked to diagnostic confirmation
- Hyperbilirubinaemia at or near exchange levels and perinatal asphyxia are the classical ANSD insults — confirm with diagnostic ABR, because OAE will be normal
- Delayed confirmation of permanent hearing loss beyond six months measurably worsens language outcomes — the clock starts at the failed screen, not the clinic appointment
- Congenital CMV is the leading non-genetic cause, and its hearing loss can be treated with valganciclovir if identified early — send the urine PCR before three weeks of life
Life stages
Care settings
Clinical exam formats
Board mappings
- Neonatology
- General and Community Paediatrics
- Newborn hearing screening and risk indicators
- Neonatal and perinatal medicine competencies
- Recognition and surveillance of the high-risk infant after NICU discharge
- Early hearing detection and intervention (EHDI) pathway
- Clinical Applications
- Newborn hearing screening, risk factors and the 1-3-6 plan
- Short Cases
- Neonatal and developmental follow-up scenarios
- 1. Good clinical care: Managing complexity
- Neonatology and the newborn examination: recognises and acts on failed hearing screen
- Foundation of Practice (FOP)
- Applied Knowledge in Practice (AKP)
- Neonatology and sensorineural hearing loss
- Clinical
- Newborn and infant developmental assessment
- Communication
- General Pediatrics Content Outline — Domain 8: Neonatal conditions
- Newborn hearing screening and congenital hearing loss
- General Pediatrics EPA: coordinate the failed newborn hearing screen
- Patient Care: newborn care and discharge planning
- Medical Knowledge: congenital and acquired neonatal hearing loss
- Systems-Based Practice: EHDI 1-3-6 pathway and loss-to-follow-up
- Medical Expert
- Newborn hearing screening and early intervention
- Pediatrics Core EPA — coordinate the high-risk infant hearing pathway
Overview & Definition
A mother holds her two-week-old baby in the neonatal unit corridor while a screen prints a result neither parent can read. The nurse explains that the baby will need a repeat test, and a quiet panic sets in — is the child deaf? The paediatrician's job at that moment is to translate a screening result into a plan, and the skill lies in knowing which babies need watching, which need confirming, and which need not worry at all. Hearing loss in high-risk neonates is the prototype of a condition where the screen is only the beginning of the story. [2]
Permanent childhood hearing loss affects roughly one to three per thousand live births in the well population, but the rate climbs steeply in the neonatal intensive care unit, where as many as two to four per cent of graduates carry permanent loss. The high-risk neonate is the infant whose exposure — prematurity, ototoxic medication, severe jaundice, asphyxia, congenital infection, or a syndromic family — places them in a category where universal screening alone is insufficient and ongoing surveillance is mandatory. [6]
The definition examiners expect separates the type of loss from its consequence. Permanent hearing loss is a sensory deficit of the cochlea or auditory pathway that is present at birth or acquired in the perinatal period and that, if undetected, impairs the acquisition of spoken language during the critical first years of life. The aim of early detection is not the diagnosis itself but the protection of language, because the brain's auditory cortex is most plastic in the first six months, and identification after that window measurably degrades outcomes. [1]
References11ShowHide
- [1]Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL Language of early- and later-identified children with hearing loss. Pediatrics, 1998.PMID 9794949
- [2]Kennedy C, McCann D, Campbell MJ, Kimm L, Thornton R Universal newborn screening for permanent childhood hearing impairment: an 8-year follow-up of a controlled trial. Lancet, 2005.PMID 16112302
- [3]Pimperton H, Kennedy CR The impact of early identification of permanent childhood hearing impairment on speech and language outcomes. Arch Dis Child, 2012.PMID 22550319
- [4]Pimperton H, Kreppner J, Mahon M, Stevenson J, Terlektsi E, Worsfold S, Yuen HM, Kennedy CR Language Outcomes in Deaf or Hard of Hearing Teenagers Who Are Spoken Language Users: Effects of Universal Newborn Hearing Screening and Early Confirmation. Ear Hear, 2017.PMID 28399063
- [5]Norton SJ, Gorga MP, Widen JE, Folsom RC, Sininger Y, Cone-Wesson B, Vohr BR, Mascher K, Fletcher K Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance. Ear Hear, 2000.PMID 11059707
- [6]Vohr BR, Widen JE, Cone-Wesson B, Sininger YS, Gorga MP, Folsom RC, Norton SJ Identification of neonatal hearing impairment: characteristics of infants in the neonatal intensive care unit and well-baby nursery. Ear Hear, 2000.PMID 11059699
- [7]American Academy of Pediatrics, Joint Committee on Infant Hearing Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics, 2007.PMID 17908777
- [8]Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I Hearing loss and congenital CMV infection: a systematic review. Pediatrics, 2014.PMID 25349318
- [9]Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med, 2015.PMID 25738669
- [10]Morlet T, Parkes W, Pritchett C, Venskytis E, DeVore B, O'Reilly RC A 15-Year Review of 260 Children With Auditory Neuropathy Spectrum Disorder: I. Demographic and Diagnostic Characteristics. Ear Hear, 2023.PMID 37036288
- [11]Chen W, Huang S, Huang Y, Duan B, Xu Z, Wang Y Short-term outcomes of infants with hyperbilirubinemia-associated auditory neuropathy spectrum disorder in neonatal intensive care unit. Int J Pediatr Otorhinolaryngol, 2023.PMID 37172369